Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: ALIGOS THERAPEUTICS INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-22 to 2026-12-31
Current total value of award: $11286393
Description: TO CONDUCT CLINICAL DEVELOPMENT OF A COMPOUND FOR THE TREATMENT OF COVID-19.